SCHEMBL13824909

SCHEMBL13824909

O=c1[nH]nc2c(CO)cc(-c3ccccc3)cn12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTK P29376 2/20 0.50
ALK Q9UM73 2/20 0.50
DYRK1B Q9Y463 2/20 0.50
CLK4 Q9HAZ1 2/20 0.50
RET P07949 1/20 0.50
MET P08581 1/20 0.50
GRK5 P34947 1/20 0.50
CDK8 P49336 1/20 0.50
RPS6KA3 P51812 1/20 0.50
MST1R Q04912 1/20 0.50
TYRO3 Q06418 1/20 0.50
DYRK1A Q13627 1/20 0.50
LRRK2 Q5S007 1/20 0.50
PDE5A O76074 3/20 0.46
PDE3B Q13370 4/20 0.42
PDE3A Q14432 4/20 0.42
CHEK1 O14757 4/20 0.38
KDR P35968 2/20 0.38
DAPK3 O43293 1/20 0.38
ABL1 P00519 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13824906 0.81 RET (0.42) LTKALKDYRK1BCLK4RET
SCHEMBL13825028 0.79 LTK (0.48) LTKALKDYRK1BCLK4RET
SCHEMBL13825030 0.77 LTK (0.46) LTKALKDYRK1BCLK4RET
SCHEMBL13933585 0.77 LTK (0.44) LTKALKDYRK1BCLK4RET
SCHEMBL13825035 0.74 HPGDS (0.48) PDE3BPDE3ACSNK1D
SCHEMBL4511564 0.71 POLB (0.40) LTKALKDYRK1BCLK4RET
SCHEMBL18632535 0.68 SCN5A (0.62) LTKALKDYRK1BCLK4RET
SCHEMBL18632530 0.68 SCN5A (0.62) LTKALKDYRK1BCLK4RET
SCHEMBL18632538 0.67 SCN5A (0.57) LTKALKDYRK1BCLK4RET
SCHEMBL13825172 0.66 KDM4E (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012150829-A2 NOBLE TRIAZOLOPYRIDINE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PRODUCTION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME 제일약품주식회사 (KR) 2012-11-08 WO disclosed